Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects With Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01352897

Enrollment

800

Registered

2011-05-12

Start date

2010-08-31

Completion date

2010-12-31

Last updated

2011-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolaemia

Keywords

Cholesterol, rosuvastatin, retrospective

Brief summary

The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Primary hypercholesterolemia * Subjects from first rosuvastatin Registry study

Design outcomes

Primary

Measure	Time frame
Percentage of patients who maintain US NCEP ATP III LDL-C target goals after long-term therapy	Up to 8 years

Secondary

Measure	Time frame
LDL-cholesterol levels	Up to 8 years
HDL-cholesterol levels	Up to 8 years
Proportion of patients having raised levels of serum CK or ALT	Up to 8 years

Countries

Singapore

Outcome results